Sox‐2 was used as a marker for glioma cells.7 Representative images of recurrent GBM tissue sections from two long‐term survivors (Figure 3a) and two short‐term survivors (Figure 3b) are shown. This evidence concerns the gene SOX2 and central nervous system cancer.